Evidence map›Paper›PMID 35960597›Full record

ArticleBiochemistry2023

Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine Development.

Payton Weidenbacher, Sriharshita Musunuri, Abigail E Powell, Shaogeng Tang, Jonathan Do, Mrinmoy Sanyal, Peter S Kim

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Payton WeidenbacherStanford ChEM-H, Stanford University, Stanford, California 94305, United States.ORCID 0000-0002-7692-0458
Sriharshita MusunuriStanford ChEM-H, Stanford University, Stanford, California 94305, United States.
Abigail E PowellStanford ChEM-H, Stanford University, Stanford, California 94305, United States.ORCID 0000-0001-6408-9495
Shaogeng TangStanford ChEM-H, Stanford University, Stanford, California 94305, United States.
Jonathan DoStanford ChEM-H, Stanford University, Stanford, California 94305, United States.
Mrinmoy SanyalStanford ChEM-H, Stanford University, Stanford, California 94305, United States.
Peter S KimStanford ChEM-H, Stanford University, Stanford, California 94305, United States.ORCID 0000-0001-6503-4541
Stanford University · USChan Zuckerberg Initiative (United States) · US

Funding

Creating high-resolution, epitope-focused vaccinesDP1AI158125 · NIAID · STANFORD UNIVERSITY · PI KIM, PETER S · 2020 to 2024
$5.9M
Cell Surface Receptor Recognition and Membrane Fusion in Mammalian FertilizationK99HD104924 · NICHD · STANFORD UNIVERSITY · PI TANG, SHAOGENG · 2021 to 2022
$383k
NIAID NIH HHS DP1 AI158125NICHD NIH HHS K99 HD104924
6 · The paper itself

Abstract

Ferritin-based, self-assembling protein nanoparticle vaccines are being developed against a range of viral pathogens, including SARS-CoV-2, influenza, HIV-1, and Epstein-Barr virus. However, purification of these nanoparticles is often laborious and requires customization for each potential nanoparticle vaccine. We propose that the simple insertion of a polyhistidine tag into exposed flexible loops on the ferritin surface (His-Fer) can mitigate the need for complex purifications and enable facile metal-chelate-based purification, thereby allowing for optimization of early stage vaccine candidates. Using sequence homology and computational modeling, we identify four sites that can accommodate insertion of a polyhistidine tag and demonstrate purification of both hemagglutinin-modified and SARS-CoV-2 spike-modified ferritins, highlighting the generality of the approach. A site at the 4-fold axis of symmetry enables optimal purification of both protein nanoparticles. We demonstrate improved purification through modulating the polyhistidine length and optimizing both the metal cation and the resin type. Finally, we show that purified His-Fer proteins remain multimeric and elicit robust immune responses similar to those of their wild-type counterparts. Collectively, this work provides a simplified purification scheme for ferritin-based vaccines.

Indexed as

COVID-19FerritinsNanoparticlesVaccine DevelopmentAntibodies, NeutralizingGlycoproteinsHumansSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingFerritinsGlycoproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35960597
PMCPMC9850919
OpenAlexW4290861578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.